Clinical and epidemiological characteristics of sepsis in children hospitalized in a level 3 hospital

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. According to literature data, more than 3 million children die from sepsis every year in the world, and the total number of diagnoses of «sepsis» in the pediatric population exceeds 25 million. Sepsis in childhood has significant differences from adult patients in clinical symptoms, course of the disease, severity of the condition and management tactics.

Objective. Evaluation of the epidemiology and etiology of septic conditions in children of different ages in a hospital setting.

Methods. A retrospective study of the risk factors, etiology and routing of 28 children of different age groups with an established diagnosis of «sepsis» who were treated in a 3rd level children’s hospital was conducted.

Results. It was shown that among the groups of pathogens, the dominant position remains with gram-negative flora, and the leading place among individual microorganisms belongs to Staphylococcus aureus. Considering that Staphylococcus aureus was also the dominant pathogen in children with respiratory infections hospitalized in the isolation and diagnostic department, the authors suggest its influence not only on the prevalence, but also on the severity of the infectious process. In 23% of cases, the diagnosis of sepsis was made on the basis of culturing one pathogen from 2 or more loci. It was also demonstrated that children of younger age groups are more prone to the development of generalized forms of the infectious process: all 28 children were under 12 years old.

Conclusions. Further study of various clinical and epidemiological aspects of the development of septic conditions will reveal the current mechanisms of infection, as well as variants of the body’s response to generalized infection, which will serve as the basis for a personalized approach to the treatment of sepsis in children.

Full Text

Restricted Access

About the authors

Kh. M. Vakhitov

Kazan State Medical University

Email: vhakim@mail.ru
ORCID iD: 0000-0001-9339-2354

Dr. Sci. (Med.), Professor

Russian Federation, Kazan

L. M. Ziyatdinova

Children’s Republican Clinical Hospital

Author for correspondence.
Email: vhakim@mail.ru
ORCID iD: 0009-0009-5592-2110
Russian Federation, Kazan

N. D. Safiullina

Kazan State Medical University

Email: vhakim@mail.ru
ORCID iD: 0009-0009-1937-1681
Russian Federation, Kazan

M. I. Ismagilova

Children’s Republican Clinical Hospital

Email: vhakim@mail.ru
ORCID iD: 0000-0002-6074-4541
Russian Federation, Kazan

D. R. Mirgalimov

Children’s Republican Clinical Hospital

Email: vhakim@mail.ru
ORCID iD: 0009-0006-4942-1844
Russian Federation, Kazan

References

  1. Лекманов А.У., Миронов П.И. Сепсис в педиатрической практике – пора договариваться. Российский вестник перинатологии и педиатрии. 2020;65(3):131–37. [Lekmanov A.U., Mironov P.I. Sepsis in pediatric practice - time to negotiate. Russian Bulletin of Perinatology and Pediatrics. 2020;65(3):131–37. (In Russ.)]. doi: 10.21508/1027-4065-2020-65-3-131-137.
  2. Rudd K.E., Johnson S.C., Agesa K.M. et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–11. doi: 10.1016/S0140-6736(19)32989-7.
  3. Weiss S.L., Fitzgerald J.C., Pappachan J., et al. Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015;191(10):1147–15. doi: 10.1164/rccm.201412-2323OC.
  4. Boeddha N., Schlapbach N., Driessen G., et al. Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS). Crit Care. 2018;22:143. doi: 10.1186/s13054-018- 2052-7.
  5. Weiss S.L., Peters M.J., Alhazzani W., et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020;46(1):10–67. doi: 10.1007/s00134-019-05878-6.
  6. Killien E.Y., Farris R.W.D., Watson R.S., et al. HealthRelated Quality of Life Among Survivors of Pediatric Sepsis. Pediatr Crit Care Med. 2019;20(6):501–9. doi: 10.1097/PCC.0000000000001886.
  7. Schlapbach L.J., Straney L., Alexander J., et al; ANZICS Paediatric Study Group. Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002-13: a multicentre retrospective cohort study. Lancet Infect Dis. 2015;15(1):46–54. doi: 10.1016/S1473-3099(14)71003-5.
  8. Watson R.S., Carcillo J.A., Linde-Zwirble W.T., et al. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med. 2003;167(5):695–701. doi: 10.1164/rccm.200207-682OC.
  9. De Souza D.C., Goncalves Martin J., Soares Lanziotti V., et al. SPREAD PED Investigators and the Instituto Latino Americano de Sepsis Network. The epidemiology of sepsis in paediatric intensive care units in Brazil (the Sepsis PREvalence Assessment Database in Pediatric population, SPREAD PED): an observational study. Lancet Child Adolesc Health. 2021;5(12): 873–81. doi: 10.1016/S2352-4642(21) 00286-8.
  10. Klingenberg C., Kornelisse R.F., Buonocore G., et al. Culture-negative early-onset neonatal sepsis - at the crossroad between efficient sepsis care and antimicrobial stewardship. Front Pediatr. 2018;6:285. doi: 10.3389/ fped.2018.00285.
  11. Schlapbach LJ, Watson RS, Sorce LR, et al. Society of Critical Care Medicine Pediatric Sepsis Definition Task Force. International Consensus Criteria for Pediatric Sepsis and Septic Shock. JAMA. 2024;331(8):665–74. doi: 10.1001/jama.2024.0179.
  12. Хаертынов Х.С. Неонатальный сепсис: микробные и иммунные факторы в диагностике и прогнозе заболевания: специальность. Автореф. дисс. докт. мед. наук. Казанский государственный медицинский университет. Электрон. текстовые дан. (372 КБ). Казань, 2019. 39 с. [Khaertynov H.S. Neonatal sepsis: microbial and immune factors in diagnosis and prognosis of the disease: specialty. Abstract of Diss. for Doct. of Med. Sciences. Kazan State Medical University. Electronic text data. (372 KB). Kazan, 2019. 39 p. (In Russ.)].
  13. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–96. doi: 10.1097/01.CCM.0000217961.75225.E9.
  14. Legrand M., De Backer D., Depret F., Ait-Oufella H. Recruiting the microcirculation in septic shock. Ann Intensive Care. 2019;9:102. doi: 10.1186/s13613-019-0577-9.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Bionika Media